Diabetes & Its Complications
Diabetes mellitus is one of the most significant and complex healthcare challenges of our time. Its growing prevalence, long-term complications and wide impact on cardiovascular, renal, neurological and metabolic health demand a comprehensive, multidisciplinary approach.
Diabetes is a central pillar of metabolic healthcare.
IMACH recognises diabetes as a central pillar of metabolic healthcare and aims to advance clinical understanding through scientific education, expert engagement and evidence-based knowledge exchange. Our focus spans the entire spectrum of care: early identification, accurate diagnosis, risk stratification, individualised treatment selection and long-term management.
The therapeutic landscape has changed rapidly. GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, modern insulin therapies and combination strategies now allow clinicians to look beyond glucose control alone, towards cardiovascular and renal protection, weight management and quality of life.
Yet the long-term burden of diabetes is largely determined by its complications — affecting the heart, kidneys, eyes, nerves and lower limbs. IMACH therefore treats complication prevention not as an afterthought but as an integral part of routine diabetes care, built on continuous risk assessment, early screening and coordinated clinical follow-up.
Key areas of scientific focus
Diagnosis & treatment
- Type 1 and Type 2 diabetes management
- Early diagnosis and screening strategies
- Individualised glycaemic targets and treatment intensification
- Newer therapeutic classes: GLP-1 RA, SGLT2i, DPP-4i
- Insulin initiation, optimisation and newer insulin technologies
- Combination treatment strategies
Technology & special populations
- Continuous glucose monitoring and digital diabetes management
- Diabetes in older adults and special populations
- Gestational diabetes and diabetes in pregnancy
- Integrated approaches to diabetes remission and prevention
- Hypoglycaemia prevention and management
- Diabetes-related cognitive dysfunction
Complications & long-term care
- Diabetic retinopathy and vision preservation
- Diabetic kidney disease
- Peripheral and autonomic neuropathy
- Diabetic foot assessment, prevention and multidisciplinary foot care
- Cardiovascular complications and peripheral arterial disease
- Diabetes-associated infections; screening and monitoring protocols
Clinical challenges we address
Clinical inertia
Delays in treatment intensification leave many patients above target for years. We focus on practical, timely decision-making.
Late detection of complications
Retinopathy, nephropathy and neuropathy are often found late. We promote structured annual screening pathways.
Choosing between therapies
With many drug classes available, selecting the right agent for each patient profile requires up-to-date, evidence-based guidance.
Hypoglycaemia and safety
Balancing tight control with safety — especially in older adults and people with kidney disease.
Adherence and self-management
Sustained outcomes depend on education, engagement and support beyond the clinic.
Fragmented care
Diabetes care often spans many specialists. We encourage coordinated, shared-care models.
Translating evidence into everyday care
IMACH emphasises the translation of contemporary guidelines and emerging clinical evidence into decisions clinicians can apply in everyday practice. Programmes discuss practical challenges — treatment selection, intensification, safety monitoring and patient counselling — through real-world case discussions.
The pathway below summarises the stages of care that IMACH education addresses.
| Care stage | Focus for clinicians |
|---|---|
| Screening & diagnosis | Risk-based screening, prediabetes detection, accurate diagnostic criteria and classification. |
| Initial management | Individualised targets, lifestyle and nutrition therapy, choice of first-line and organ-protective agents. |
| Intensification | Timely escalation, combination therapy, insulin initiation and titration. |
| Monitoring & technology | HbA1c, CGM metrics, time-in-range, remote monitoring. |
| Complication prevention | Annual eye, kidney, foot, nerve and cardiovascular assessment. |
| Long-term care | Ageing, multimorbidity, de-intensification where appropriate, quality of life. |
IMACH programmes in this area
Diabetes masterclasses
Advanced sessions on therapy selection, insulin optimisation and complex cases.
CGM & digital diabetes workshops
Hands-on interpretation of glucose data and technology-enabled care.
Complication screening programmes
Structured training on eye, kidney, foot and nerve assessment.
Case-based learning
Multidisciplinary case discussions on real-world clinical dilemmas.
Expert consensus initiatives
Practical recommendations adapted to clinical practice settings.
Educator & nurse modules
Self-management education, insulin technique and patient counselling.
Who this area brings together
Diabetes care is inherently multidisciplinary. IMACH connects the professionals involved at every stage of the patient journey.
Questions we explore
- How should therapy be individualised across different patient profiles and comorbidities?
- When and how should treatment be intensified to avoid clinical inertia?
- How can CGM and digital tools be integrated into routine practice?
- What is the role of remission-focused and preventive strategies?
- How can complication screening be made routine and reliable?
- How should targets be adapted for older adults and people with multimorbidity?
Frequently asked questions
Why are diabetes and its complications covered together?
Because complications drive most of the long-term burden of diabetes. Treating diabetes well means preventing and detecting complications early, so IMACH addresses both within one integrated therapy area.
Does IMACH cover Type 1 diabetes?
Yes. IMACH programmes address Type 1 and Type 2 diabetes, gestational diabetes and diabetes in special populations.
Are programmes suitable for diabetes educators and nurses?
Yes. Dedicated modules cover self-management education, insulin technique, hypoglycaemia and patient support.
How can I contribute as faculty?
Experienced clinicians can express interest through the Contact page or as part of their membership.
This page is intended for healthcare professionals and is educational in nature. It does not constitute medical advice or treatment recommendations for individual patients. Clinical decisions should follow current guidelines, local regulations and individual patient assessment.
Contribute to diabetes care at IMACH.
Join as a member, faculty or research collaborator in this therapy area.